|
|
Patterns and predictors of symptoms, falls, and functioning across treatment and recovery in patients treated with neurotoxic chemotherapy for cancer |
| 5 R01 CA222605-04 |
|
NCI |
2021 |
|
|
Optimizing functional recovery of breast cancer survivors |
| 5 R01 CA225792-03 |
|
NCI |
2021 |
|
|
Predicting Long-Term Chemotherapy-Related Cognitive Impairment |
| 5 R01 CA226080-03 |
|
NCI |
2021 |
|
|
Ameliorating lymphocyte depletion and functional impairment following lung SBRT |
| 5 R01 CA234281-03 |
|
NCI |
2021 |
|
|
Duloxetine to Prevent Oxaliplatin-Induced Chemotherapy-Induced Peripheral Neuropathy: A Randomized, Double-Bind, Placebo-Controlled Phase II to Phase III Study |
| 5 R01 CA235726-03 |
|
NCI |
2021 |
|
|
A Mobile Health Behavioral Pain Intervention Protocol for Breast Cancer Patients with Pain in Medically Underserved Communities: A Randomized Controlled Trial |
| 5 R01 CA237892-02 |
|
NCI |
2021 |
|
|
MRI study of chemobrain in pediatric oncology patients |
| 5 R01 CA244768-02 |
|
NCI |
2021 |
|
|
Life after breast cancer treatment: racial health disparities and chronic pain in breast cancer survivors. |
| 5 R01 CA246708-02 |
|
NCI |
2021 |
|
|
Preventing Falls and Frailty in Prostate Cancer Survivors: GET FIT Prostate |
| 5 R01 CA248059-02 |
|
NCI |
2021 |
|
|
AC/DC: Artificial intelligence and Computer visioning to assess Dietary Composition |
| 5 R21 CA250024-02 |
|
NCI |
2021 |
